{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:52:28Z","timestamp":1769521948261,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"University of British Columbia Pathology Residency Training Program"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.humpath.2020.08.010","type":"journal-article","created":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T11:14:55Z","timestamp":1599563695000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["c-MET immunohistochemistry for differentiating malignant mesothelioma from benign mesothelial proliferations"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2779-7297","authenticated-orcid":false,"given":"He Zhen","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2020.08.010_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001565","article-title":"The separation of benign and malignant mesothelial proliferations: new markers and how to use them","author":"Churg","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.08.010_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1158\/0008-5472.CAN-04-4567","article-title":"Functional analysis of c-met\/hepatocyte growth factor pathway in malignant pleural mesothelioma","volume":"66","author":"Jagadeeswaran","year":"2006","journal-title":"Canc Res"},{"key":"10.1016\/j.humpath.2020.08.010_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41568-018-0002-y","article-title":"Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy","volume":"18","author":"Comoglio","year":"2018","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.humpath.2020.08.010_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10555-007-9107-6","article-title":"The Met tyrosine kinase receptor in development and cancer","volume":"27","author":"Gentile","year":"2008","journal-title":"Canc Metastasis Rev"},{"key":"10.1016\/j.humpath.2020.08.010_bib5","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.18632\/oncotarget.3420","article-title":"Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets","volume":"6","author":"Chang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2020.08.010_bib6","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s41388-018-0537-0","article-title":"Overexpression-mediated activation of MET in the Golgi promotes HER3\/ERBB3 phosphorylation","volume":"38","author":"Frazier","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2020.08.010_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/JTO.0b013e3182417da5","article-title":"Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH group","volume":"7","author":"Levallet","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.humpath.2020.08.010_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anndiagpath.2016.04.007","article-title":"c-Met expression and MET amplification in malignant pleural mesothelioma","volume":"23","author":"Bois","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2020.08.010_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/(SICI)1096-9896(199612)180:4<389::AID-PATH685>3.0.CO;2-K","article-title":"Immunoreactivity for hepatocyte growth factor\/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas","volume":"180","author":"Harvey","year":"1996","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2020.08.010_bib10","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1365-2559.2000.00888.x","article-title":"Immunoreactivity for cadherins, HGF\/SF, met, and erbB-2 in pleural malignant mesotheliomas","volume":"36","author":"Thirkettle","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.08.010_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/his.13872","article-title":"Cytoplasmic MTAP expression loss detected by immunohistochemistry correlates with 9p21 homozygous deletion detected by FISH in pleural effusion cytology of mesothelioma","volume":"75","author":"Hamasaki","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.08.010_bib12","doi-asserted-by":"crossref","first-page":"16215","DOI":"10.18632\/oncotarget.3976","article-title":"MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)","volume":"6","author":"Casadevall","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2020.08.010_bib13","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1158\/1078-0432.CCR-05-1191","article-title":"Inhibition of the met receptor in mesothelioma","volume":"11","author":"Mukohara","year":"2005","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.humpath.2020.08.010_bib14","first-page":"1347","article-title":"Evaluation of the c-Met immunostain to detect malignant cells in body cavity effusions","volume":"8","author":"Zimmerman","year":"2001","journal-title":"Oncol Rep"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:37:15Z","timestamp":1758645435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817720301726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":14,"alternative-id":["S0046817720301726"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2020.08.010","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"c-MET immunohistochemistry for differentiating malignant mesothelioma from benign mesothelial proliferations","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2020.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}